Skip to main content
. 2010 Oct 27;60(2):207–215. doi: 10.1007/s00262-010-0932-z

Table 1.

Patient profiles and administration site of APCs

Case Age/gender Tumor lesion Stage Past treatment Labelled APCs Unlabelled APCs
001 64/M Larynx T2N2c CT NS
002 63/M Hypopharynx T3N2b RT NS
003 65/M Tongue T2N1 OP NS
004 64/M Hypopharynx T3N1 CT, RT NS
005 48/M Maxilla T4N0 CT, RT NS
006 68/M Hypopharynx T4N0 RT NS
007 76/M Larynx T2N0 RT NS
008 57/M Oral floor T4N2b OP OF
009 71/F Hypopharynx T2N0 CT, RT OF
010 76/M Larynx T1aN0 RT OF
011 64/M Tongue T1N0 OP OF
012 64/M Larynx T4N0 CT, RT, OP OF
013 48/M Oropharynx T2N2b CT, RT, OP OF
014 40/F Tongue T2N2b CT, RT, OP OF
015 67/F Maxilla T4N0 CT, RT, OP OF
016 36/M Larynx T4N0 CT, RT OF
017 71/F Tongue T1N0 OP OF

CT chemotherapy, RT radiation therapy, OP operation therapy NS nasal submucosa, OF oral floor submucosa